DA-9201 shows anti-asthmatic effects by suppressing NF-кB expression in an ovalbumin-lnduced mouse model of asthma

被引:8
作者
Seung-Ho Lee
Mi Jung Seo
Seul Min Choi
Yong Sung Sohn
Kyung Koo Kang
Byoung Ok Ahn
Jong Won Kwon
Moohi Yoo
机构
[1] Research Institutes of Dong-A Pharmaceutical Company,
来源
Archives of Pharmacal Research | 2005年 / 28卷
关键词
Asthma; DA-9201; NF-кB; Anti-inflammatory; Mice model;
D O I
暂无
中图分类号
学科分类号
摘要
Nuclear factor kappa (NF-кB) regulates the expression of multiple cytokines, chemokines, and cell adhesion molecules that are involved in the pathogenesis of asthma. We investigated the anti-asthmatic effects and the mechanism of action of DA-9201, an extract of the black rice, in a mouse model of asthma. Mice immunized with ovalbumin (OVA) were administered with DA-9201 (30, 100 or 300 mg/kg) or dexamethasone (DEXA, 3 mg/kg) for 2 weeks and challenged with aerosolized OVA during the last 3 days. Anti-asthmatic effects were assessed by means of enhanced pauses, level of total IgE and Th2 cytokines in plasma or bronchoalve-olar lavage fluid (BALF), the percentage of eosinophils in BALF, and histopathological examination. The expression of NF-кB in nuclear and cytoplasmic fraction and its DNA-binding activity in lung tissues were analyzed by means of Western blotting and electrophoretic gel mobility shift assay (EMSA), respectively. DA-9201 significantly reduced airway hyperrespon-siveness (AHR), total IgE level in plasma and BALF, IL-4, IL-5, and IL-13 levels in BALF, and the percentage of eosinophils in BALF. Tissue inflammation was significantly improved by DA-9201 treatment. In addition, DA-9201 dramatically suppressed the expression of NF-кB and its DNA-binding activity. These results suggest that DA-9201 may be useful for the treatment of asthma and its efficacy is related to suppression of NF-кB pathway.
引用
收藏
页码:1350 / 1357
页数:7
相关论文
共 112 条
[1]
Baeuerle P. A.(1996)NF-кB: ten years after Cell 87 13-20
[2]
Baltimore D.(1996)The NF-кB and IkB proteins: new discoveries and insights Annu. Rev. Immunol. 14 649-681
[3]
Baldwin A. S.(1997)Nuclear factor-кB: a pivotal transcription factor in chronic inflammatory disease N. Engl. J. Med. 336 1066- 1071
[4]
Barnes P. J.(1998)Inhaled corticosteroids: current products and their role in patient care J. Allergy Clin. Immunol. 101 S400-402
[5]
Bleecker E.(2000)Correlation between nuclear factor-кB activity in bronchial brushing samples and lung dysfunction in an animal model of asthma Am. J. Respir. Crit Care. Med. 161 1314-1321
[6]
Bureau F.(2001)A quinolone alkaloid with anti-oxidant activity from the aleurone layer of anthocyanin-pigmented rice N. Engl. J. Med. 344 350-362
[7]
Bonizzi G.(2001)A critical role for NF-KB in GATA3 expression and TH2 differentiation in allergic airway inflammation J. Nat. Prod. 64 1579-1580
[8]
Kirschvink N.(2001)Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions Nat. Immunol. 2 45-50
[9]
Delhalle S.(1985)NF-кB and Rei proteins: evolutionary conserved mediators of immune responses Am. Rev. Respir. Dis. 131 373-376
[10]
Desmecht D.(1998)A new 2-arylbenzofuran with antioxidant activity from the black colored rice (Oryza sativa L.) bran Annu. Rev. Immunol. 16 225-260